Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
|
|
Hyperfine, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Re: Transition From Part-Time Employee to Consultant Dear Khan, Thank you for your longstanding contributions to Hyperfine. This agreement sets forth the Separation Agreement between you and Hyperfine, Inc. regarding your transition from part-time employee to consultant. In consideration of the mutual promises set forth in this letter, you and Hyperfine agree to the following: 1. Separation Date. Your employment separation date is September 30, 2023 . You understand that Hyperfine will continue payment of your base salary in accordance with Hyperfine’s regular payroll practices, less all applicable taxes and other withholdings, through the Separation Date. In addition, in consideration for your entering into this Agreement, including, without limitation, your agreement to Section 4 hereof,...",
"HYPERFINE, INC. CONSULTING AGREEMENT This Consulting Agreement is made and entered into as of September 30th, 2023 by and among Hyperfine, Inc. , a Delaware corporation located at 351 New Whitfield Street, Guilford, CT 06437, and Dr. Khan Siddiqui , having a notice address as described below. WHEREAS, Consultant represents Consultant has the necessary qualifications, experience, expertise, and abilities to provide consulting services required by the Company and desires to be engaged in the capacity of independent contractor in accordance with the terms and conditions set forth in this Agreement; and WHEREAS, Consultant was Chief Medical Officer & Chief Strategy Officer for Company, and is transitioning from a part-time employee to serving as a consultant of the Company, and the Consultant ..." |
|
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
8-K
| Quarterly results|
Docs:
|
"HYPERFINE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS June 30, 2023 December 31, 2022 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 93,948 $ 117,472 Restricted cash 969 771 Accounts receivable, less allowance of $175 and $180 as of June 30, 2023 and December 31, 2022, respectively 3,948 2,103 Unbilled receivables 663 454 Inventory 5,983 4,622 Prepaid expenses and other current assets 2,312 3,194 Due from related parties — 48 Total current assets 107,823 128,664 Property and equipment, net 3,058 3,248 Other long term assets 1,725 2,139 Total assets $ 112,606 $ 134,051 LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES: Accounts payable $ 1,372 $ 678 Deferred grant funding 969 771 Deferred revenue 1,490 1,378 Due to related parties 45 — Accrued expenses and other..." |
|
| 07/24/2023 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/18/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Promotional Grant Stock Options 200,000 The Stock Options will have an exercise price equal to the closing price of our Class A Common Stock on the grant date, will be subject to the terms of the grant documents therefore, and subject to continued service and the specific terms of your grant, will vest over a four-year period as follows: 25% on the one-year anniversary of the Effective Date and 2.083% at the end of each full month thereafter. Additional information with respect to this award will be forthcoming at the time of grant. Except as we’ve outlined above, the provisions of your employment terms will continue to remain in effect . If you have any questions, of course, please do not hesitate to contact me. 1 Tom, congratulations again and we look forward to your continued success!",
"$87,360 per year , which will be paid according to the Company’s standard payment schedule.",
"PLAN DOCUMENT AND SUMMARY PLAN DESCRIPTION Effective as of July 24, 2023 1. Establishment of Plan. Hyperfine Operations, Inc., Liminal Sciences, Inc., and Hyperfine, Inc. , hereby establishes an unfunded severance benefits plan that is intended to be a welfare benefit plan within the meaning of Section 3 of ERISA. This Plan is in effect for Participants who experience certain terminations of employment occurring after the Effective Date and before the termination of this Plan. This Plan supersedes any and all severance plans and separation policies applying to Participants that may have been in effect before the Effective Date with respect to any termination that would, under the terms of this Plan, constitute a termination by the Company without Cause or by Participant for Good Reason, an...",
"Investor Contact Marissa Bych Gilmartin Group LLC [email protected]" |
|
| 07/03/2023 |
4/A
| Fattori Ruth A (Director) has filed a Form 4 on Hyperfine, Inc.|
Txns:
| Granted 112,000 options to buy
@ $1.97, valued at
$220.6k
Granted 85,000 options to buy
@ $1.97, valued at
$167.5k
|
|
| 07/03/2023 |
4/A
| Wolterman Dan (Director) has filed a Form 4 on Hyperfine, Inc.|
Txns:
| Granted 112,000 options to buy
@ $1.97, valued at
$220.6k
Granted 85,000 options to buy
@ $1.97, valued at
$167.5k
|
|
| 06/12/2023 |
4
| Wolterman Dan (Director) has filed a Form 4 on Hyperfine, Inc.|
Txns:
| Granted 112,000 options to buy
@ $1.97, valued at
$220.6k
Granted 85,000 options to buy
@ $1.97, valued at
$167.5k
|
|
| 06/12/2023 |
4
| Fattori Ruth A (Director) has filed a Form 4 on Hyperfine, Inc.|
Txns:
| Granted 112,000 options to buy
@ $1.97, valued at
$220.6k
Granted 85,000 options to buy
@ $1.97, valued at
$167.5k
|
|
| 06/12/2023 |
4
| Dahldorf John T (Director) has filed a Form 4 on Hyperfine, Inc.|
Txns:
| Granted 112,000 options to buy
@ $1.97, valued at
$220.6k
Granted 85,000 options to buy
@ $1.97, valued at
$167.5k
|
|
| 06/12/2023 |
4
| Huennekens R Scott (Director) has filed a Form 4 on Hyperfine, Inc.|
Txns:
| Granted 112,000 options to buy
@ $1.97, valued at
$220.6k
Disposed/sold 237,437 options to buy
@ $0.91, valued at
$216.1k
Granted 237,437 options to buy
@ $1.97, valued at
$467.8k
|
|
| 06/12/2023 |
4
| ROTHBERG JONATHAN M (10% Owner) has filed a Form 4 on Hyperfine, Inc.|
Txns:
| Granted 112,000 options to buy
@ $1.97, valued at
$220.6k
|
|
| 06/12/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...|
Docs:
|
"AMENDED AND RESTATED BYLAWS OF HYPERFINE, INC.",
"CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF HYPERFINE, INC. It is hereby certified that: FIRST: The name of the corporation is Hyperfine, Inc. . SECOND: The Certificate of Incorporation of the Corporation, as amended , is hereby further amended by striking out Article X in its entirety and by substituting in lieu of the following: LIMITATION OF DIRECTOR AND OFFICER LIABILITY To the fullest extent permitted by the DGCL as the same exists or as may hereafter be amended, a director or officer of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or an officer; provided, however, that nothing contained in this Article X shall eliminate or limit the liability of a director or an of...",
"HYPERFINE, INC. NONEMPLOYEE DIRECTOR COMPENSATION POLICY The Board of Directors of Hyperfine, Inc. has approved the following Nonemployee Director Compensation Policy to provide an inducement to obtain and retain the services of qualified persons to serve as members of the Company’s Board of Directors. The Policy establishes compensation to be paid to nonemployee directors of the Company. Applicable Persons This Policy shall apply to each director of the Company who is not an employee of the Company or any Affiliate . “Affiliate” shall mean an entity which is a direct or indirect parent or subsidiary of the Company, as determined pursuant to Section 424 of the Internal Revenue Code of 1986, as amended. Compensation A. Equity Grants 1. Annual Grants Each Outside Director shall..." |
|
| 05/25/2023 |
4
| Siddiqui Khan (See Remarks) has filed a Form 4 on Hyperfine, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.4, valued at
$140k
|
|
| 05/16/2023 |
4
| Siddiqui Khan (CMO and Chief Strategy Officer) has filed a Form 4 on Hyperfine, Inc.|
Txns:
| Sold 1,735 shares
@ $1.25, valued at
$2.2k
|
|
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results|
Docs:
|
"HYPERFINE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS March 31, 2023 December 31, 2022 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 104,027 $ 117,472 Restricted cash 713 771 Accounts receivable, less allowance of $191 and $180 as of March 31, 2023 and December 31, 2022, respectively 3,018 2,103 Unbilled receivables 713 454 Inventory 5,744 4,622 Prepaid expenses and other current assets 2,923 3,194 Due from related parties — 48 Total current assets 117,138 128,664 Property and equipment, net 3,091 3,248 Other long term assets 1,873 2,139 Total assets $ 122,102 $ 134,051 LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES: Accounts payable $ 1,668 $ 678 Deferred grant funding 713 771 Deferred revenue 1,415 1,378 Due to related parties 64 — Accrued expenses and ot..." |
|
| 04/24/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/24/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/24/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/29/2023 |
8-K
| Quarterly results |
| 03/22/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/22/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/22/2023 |
8-K/A
| Quarterly results |
| 03/21/2023 |
8-K
| Quarterly results|
Docs:
|
"HYPERFINE, INC. AND SUBSIDIARIES COMBINED AND CONSOLIDATED BALANCE SHEETS December 31, December 31, 2022 2021 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 117,472 $ 188,498 Restricted cash 771 2,662 Accounts receivable, net 2,103 553 Unbilled receivables 454 91 Inventory 4,622 4,310 Prepaid expenses and other current assets 3,194 1,357 Due from related parties 48 14 Total current assets $ 128,664 $ 197,485 Property and equipment, net 3,248 3,753 Other long term assets 2,139 1,235 Total assets $ 134,051 $ 202,473 LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES: Accounts payable $ 678 $ 2,248 Deferred grant funding 771 2,662 Deferred revenue 1,378 730 Due to related parties — 1,981 Accrued expenses and other current liabilities 5,976 8,115 Total current liabilities $ 8,803 $ ..." |
|
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/14/2023 |
SC 13G/A
| HC Sponsor LLC has filed a Schedule 13D for Hyperfine, Inc. |
| 02/08/2023 |
8-K
| Quarterly results |
| 01/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/24/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
|
|
|